Get the Stockscreener App
87.88
0.74%
0.925
Iradimed Corp stock is traded at $87.88, with a volume of 77,213.
It is up +0.74% in the last 24 hours and down -9.73% over the past month.
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
See More
Previous Close:
$86.95
Open:
$86.46
24h Volume:
77,213
Relative Volume:
0.55
Market Cap:
$1.12B
Revenue:
$86.28M
Net Income/Loss:
$23.61M
P/E Ratio:
47.86
EPS:
1.8359
Net Cash Flow:
$23.97M
1W Performance:
-2.97%
1M Performance:
-9.73%
6M Performance:
-12.95%
1Y Performance:
+24.45%
1-Day Range:
$85.57
$87.80
1-Week Range:
$85.00
$92.70
52-Week Range:
$67.84
$107.90
Iradimed Corp Stock (IRMD) Company Profile
Name
Iradimed Corp
Sector
Industry
Phone
(407) 677-8022
Address
12705 INGENUITY DRIVE, ORLANDO
Compare IRMD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRMD
Iradimed Corp
|
87.63 | 1.11B | 86.28M | 23.61M | 23.97M | 1.8359 |
ABT
Abbott Laboratories
|
110.18 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
332.61 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
90.61 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.55 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.88 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-23 | Initiated | Lake Street | Buy |
| Oct-31-17 | Resumed | ROTH Capital | Buy |
| Oct-05-16 | Downgrade | ROTH Capital | Buy → Neutral |
| Nov-02-15 | Reiterated | ROTH Capital | Buy |
| Jul-30-15 | Reiterated | ROTH Capital | Buy |
| Jun-16-15 | Reiterated | ROTH Capital | Buy |
| Jan-12-15 | Reiterated | ROTH Capital | Buy |
| Dec-23-14 | Reiterated | ROTH Capital | Buy |
View All
Iradimed Corp Stock (IRMD) Latest News
IRMD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
iRadimed Corporation (NASDAQ:IRMD) Given Consensus Recommendation of "Moderate Buy" by Brokerages - marketbeat.com
IRadimed (IRMD) Q2 2026 Earnings Call Transcript - webull.com
iRadimed (NASDAQ:IRMD) Cut to "Hold" at Wall Street Zen - marketbeat.com
Iradimed Stock Price Forecast. Should You Buy IRMD? - StockInvest.us
How IRADIMED's Modest Q2 Beat and Reaffirmed 2026 Guidance Will Impact IRMD Investors - Yahoo Finance
Replacement Cycle Anchors IRadimed Corp.’s (IRMD) Long Term Growth - Yahoo Finance
Reaffirmed 2026 Guidance and Dividend Policy Could Be A Game Changer For IRADIMED (IRMD) - simplywall.st
IRadimed Corp Earnings Call Highlights Ramp, Resilience - TipRanks
iRadimed Corp (IRMD) (Q2 2026) Earnings Call Highlights: Strong Demand for New 3,870 Pump ... - Yahoo Finance
IRADIMED (IRMD) Stock Drops As 3870 Ramp Cuts Gross Margin - Sahm
iRadimed (NASDAQ:IRMD) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS - marketbeat.com
IRadimed Corp reports results for the quarter ended June 30Earnings Summary - tradingview.com
Earnings call transcript: IRadimed tops Q2 2026 estimates as 3870 ramp weighs margins - Investing.com
IRADIMED ($IRMD) Releases Q2 2026 Earnings - Quiver Quantitative
IRadimed: Q2 Earnings Snapshot - kens5.com
iRadimed (NASDAQ:IRMD) Sees Large Volume IncreaseHere's What Happened - marketbeat.com
Iradimed earnings on deck as growth momentum faces Q2 test - Investing.com
Record Results, New MRI Pump And Dividend Hike Might Change The Case For Investing In IRADIMED (IRMD) - Sahm
Renaissance Technologies LLC Sells 15,700 Shares of iRadimed Corporation $IRMD - marketbeat.com
iRadimed (IRMD) Still Has a High-Quality Niche Story, but the Valuation Debate Is Getting Harder - AlphaStreet
Iradimed Corporation (IRMD) Sales Reflects The Fund’s Valuation and Sizing Discipline - Yahoo Finance
IRadimed Corp (IRMD) Institutional Confidence - TradingKey
IRadimed Corp (IRMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IRadimed Corp (IRMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IRadimed Corp (IRMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IRadimed Corp (IRMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IRadimed Corp (IRMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IRMD|IRadimed Corp|Price:94.860|Chg%:+0.370 - TradingKey
IRadimed Corp (IRMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
IRMD|IRadimed Corp|Price:94.490|Chg%:+0.630 - TradingKey
IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026 - The Manila Times
Before market open, IRADIMED will release Q2 results July 31 - Stock Titan
IRADIMED (IRMD) As MRI Pump Upgrade Narrative Points To Fair Value Above The Stock - Sahm
IRADIMED CORPORATION (IRMD) Options Chain - Yahoo! Finance Canada
Iradimed Corp (IRMD) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Copeland Capital Management LLC Sells 53,225 Shares of iRadimed Corporation $IRMD - MarketBeat
iRadimed (IRMD) Q1 2026 Earnings: EPS Surprise Beats Estimates, Revenue Details Not DisclosedPeak Earnings Alert - po-news-eg.net
Price to book forward of IRadimed Corp. – LS:A118V4 - TradingView
IRADIMED CORP (IRMD) Stock Chart - ChartMill
IRMDIradimed Corp Latest SEC Filings - Finviz
Price to book forward of IRadimed Corp. – HAN:46K - TradingView
Enterprise value to EBITDA forward of IRadimed Corp. – HAN:46K - TradingView
Enterprise value to revenue forward of IRadimed Corp. – HAN:46K - TradingView
IRadimed Corp. Actuals & Estimates (DUS:46K) - TradingView
IRadimed Corp. Actuals & Estimates (NASDAQ:IRMD) - TradingView
46K Forecast — Price Target — Prediction for 2027 - TradingView
IRADIMED Corporation Form 8-K Filing Summary: Company Details and NASDAQ Listing Information (June 24, 2026) - Minichart
Iradimed (NASDAQ: IRMD) investors approve directors, auditor and pay - Stock Titan
Form 4 Iradimed Co For: 23 June By Investing.com - Investing.com Australia
IRADIMED (IRMD) CFO converts RSUs to stock and uses 2,319 shares for taxes - Stock Titan
Iradimed Corp Stock (IRMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):